Clinical trial

Immunotherapy in Treating Patients With Metastatic Breast Cancer

NCT00003432

StatusTERMINATED

Study typeINTERVENTIONAL

Start date1998-06-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)1998-06-01Date precision: month

Registry last updated2013-11-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

carcinoembryonic antigen RNA-pulsed DC cancer vaccineBIOLOGICAL

Sponsors & collaborators

Duke Universitylead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003432 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.